Document:

arex-ex101_6.htm

GLOBAL COMPROMISE SETTLEMENT AGREEMENT 

AND MUTUAL GENERAL RELEASE

 

This Global Compromise Settlement Agreement and Mutual General Release (“Settlement Agreement”) is made and entered into by and among the Parties and is effective as of the Effective Date.

I.PARTIES

The parties to this Settlement Agreement are the following:

1.01.Approach Resources Inc., a Delaware corporation.

1.02.Approach Midstream Holdings LLC, a Delaware limited liability company.

1.03.Approach Oil & Gas Inc., a Delaware corporation.

1.04.Approach Operating, LLC, a Delaware limited liability company.

1.05.Approach Delaware, LLC, a Delaware limited liability company.

1.06.Approach Services, LLC, a Delaware limited liability company.

1.07.Approach Resources I, LP, a Texas limited partnership.

1.08.Alpine Energy Acquisitions, LLC, a Delaware limited liability company.

1.09.Alpine Energy Capital, LLC, a Delaware limited liability company.  

II.Definitions

2.01.“Alpine Acquisitions” means Alpine Energy Acquisitions, LLC, a Delaware limited liability company.

2.02.“Alpine Capital” means Alpine Energy Capital, LLC, a Delaware limited liability company.

2.03.“Alpine Entities” means Alpine Acquisitions and Alpine Capital.

2.04.“Alpine Releasees” means the Alpine Entities, together with their respective affiliated or associated entities of whatever kind and the respective principals, past or present 

officers, directors, shareholders, managers, members, partners, employees, attorneys, agents, representatives, subsidiaries, parent entities, participants, heirs, assigns, insurance carriers, successors of the Alpine Entities and their respective affiliated or associated entities, and all persons, natural or corporate, in privity with them.

2.05.“Approach Delaware” means Approach Delaware, LLC, a Delaware limited liability company.

2.06.“Approach LP” means Approach Resources I, LP, a Texas limited partnership.

2.07.“Approach Midstream” means Approach Midstream Holdings LLC, a Delaware limited liability company.

2.08.“Approach O&G” means Approach Oil & Gas Inc., a Delaware corporation.

2.09.“Approach Operating” means Approach Operating, LLC, a Delaware limited liability company.

2.10.“Approach Services” means Approach Services, LLC, a Delaware limited liability company.

 2.11.“Bankruptcy Cases” means the bankruptcy cases of any of the Debtors, which are being jointly administered under Case Number 19-36444 (MI).

2.12.“Bankruptcy Court” means the United States Bankruptcy Court for the Southern District of Texas, Houston Division.

2.13.“Bankruptcy Court Approval Order” means an order (a) that the Bankruptcy Court enters in the Bankruptcy Cases approving this Settlement Agreement; and (b) that all Parties have approved as to form and substance. 

2.14.“Closing Date” means 4:00 p.m. Central Time on the date that is two (2) business days after the Effective Date, so long as no order staying the effectiveness of the Bankruptcy Court 

Approval Order has been entered.  If an order staying the effectiveness of the Bankruptcy Court Approval Order has been entered, the Closing Date shall be two (2) business days after such stay terminates, provided that the Bankruptcy Court Approval Order has not been reversed or vacated in part or in whole.

2.15.“Company” means Approach Resources Inc., a Delaware corporation.

2.16.“Debtors” means the Company, Approach Midstream, Approach O&G, Approach Operating, Approach Delaware, Approach Services, and Approach LP.

2.17.“Debtor Releasees” means the Debtors, together with their respective affiliated or associated entities of whatever kind and the respective principals, past or present officers, directors, shareholders, managers, members, partners, employees, attorneys, agents, representatives, subsidiaries, parent entities, participants, heirs, assigns, insurance carriers, successors, estates, trustees of the Debtors and their respective affiliated or associated entities, and all persons, natural or corporate, in privity with them.

2.18.“Disputes” means any matter raised in the Notice, the Debtor’s written response to the Notice dated March 31, 2020, the Motion to Compel, the Motion to Enforce, and the Motion to Strike, or any matter, arising out of the same facts, transactions or occurrences, that was or could have been asserted by any Party.

2.19.“Effective Date” means the date on which the Bankruptcy Court enters the Bankruptcy Court Approval Order, provided that the Bankruptcy Court enters the Bankruptcy Court Approval Order in the form attached to this Settlement Agreement as Exhibit D.

2.20.“Escrow Agent” has the meaning assigned to it in the Purchase Agreement.

2.21.“Escrow Account” has the meaning assigned to it in the Purchase Agreement.

2.22.“Escrow Agreement” has the meaning assigned to it in the Purchase Agreement. 

2.23.“Escrowed Funds” has the meaning assigned to it in the Purchase Agreement.

2.24.“Execution Date” means the date on which the last signature of the Parties is obtained on this Settlement Agreement.

2.25.“Joint Written Direction” means the joint written direction attached as Exhibit B to this Settlement Agreement.

2.26.“Motion to Compel” means the Motion for Entry of an Order Compelling (a) Debtors’ Payment of Expense Reimbursement Amount and (b) Return of Escrowed Funds [Dkt. No. 346].

2.27.“Motion to Enforce” means the Emergency Motion for Entry of an Order (i) Enforcing Sale Order and Asset Purchase Agreement; (ii) Compelling Performance; and (iii) Awarding Fees and Expenses Incurred by the Debtors’ Estates as a Result of Delayed Closing [Dkt. No. 356].

2.28.“Motion to Strike” means the Emergency Motion to Strike Evidence and Testimony [Dkt. No. 433].

2.29.“Notice” means the letter dated March 26, 2020 from Alpine Acquisitions to the Debtors.

2.30.“Parties” means the Company, Approach Midstream, Approach O&G, Approach Operating, Approach Delaware, Approach Services, Approach LP, Alpine Acquisitions, and Alpine Capital.  The Parties may be referred to individually as a “Party.”

2.31.“Purchase Agreement” means that certain Asset Purchase Agreement, dated as of February 4, 2020, by and among Alpine Acquisitions, the Company, and certain direct and indirect wholly owned subsidiaries of the Company, and joined in for certain purposes by Alpine Capital.  The Purchase Agreement is attached as Exhibit A.

2.32.“Sellers” means the Company, Approach O&G, Approach LP, Approach Operating, and Approach Services.

2.33.“Settlement Agreement” means this Global Compromise Settlement Agreement and Mutual General Release, including all attached exhibits and schedules, which are expressly incorporated into this Settlement Agreement as if set forth fully herein.

2.34.“Settlement Amount” means (a) the total amount of the Escrowed Funds, which includes the principal amount of NINETEEN MILLION TWO-HUNDRED FIFTY-THOUSAND U.S. DOLLARS ($19,250,000.00), together with any investment earnings or income thereon; and (b) the amount of TWO MILLION EIGHT-HUNDRED SEVENTY-FIVE THOUSAND U.S. DOLLARS ($2,875,000.00).

III.Recitals

3.01.On November 18, 2019, the Debtors filed the Bankruptcy Cases in the Bankruptcy Court.    

3.02.On February 4, 2020, Sellers and the Alpine Entities executed the Purchase Agreement.    

3.03.On March 4, 2020, the Bankruptcy Court entered the Order Approving (a) The Sale Of Substantially All Of The Debtors’ Assets Free And Clear Of All Liens, Claims, Encumbrances And Interests; And (b) The Assumption And Assignment Of Certain Contracts And Unexpired Leases [Dkt. No. 301].

3.04.On March 26, 2020, Alpine Acquisitions sent the Debtors the Notice, which notified the Debtors that Alpine Acquisitions intended to terminate the Purchase Agreement.

3.05.On March 31, 2020, the Debtors responded to the Notice in a written letter to Alpine Acquisitions.

3.06.On April 1, 2020, Alpine Acquisitions filed the Motion to Compel.  

3.07.On April 6, 2020, the Debtors filed the Motion to Enforce.

3.08.On May 4, 2020, the Debtors filed the Motion to Strike.  

3.09.The Parties now desire to settle the Disputes.

3.10.By executing this Settlement Agreement, no Party hereto concedes any legal or factual contentions of the other Party, but specifically denies same and enters into this Settlement Agreement solely to terminate and settle the Disputes between themselves in an effort to minimize costs, expenses, attorneys’ fees, and, most of all, for peace.  

3.11.The Parties have negotiated and reached this Settlement Agreement in good faith, each represented by counsel. 

3.12.The Parties acknowledge that this Settlement Agreement is subject to approval by the Bankruptcy Court.

IV.Scope of Settlement Agreement

4.01.Bona fide disputes and controversies exist, both as to the fact and extent of liability, if any, and as to the fact and extent of damages, if any, of any Party.  By reason of such disputes and controversies, and in order to avoid the expense and inconvenience of further litigation, the Parties desire to settle all claims, causes of action, contentions, and allegations that have been or could be asserted against each of them in the Disputes.

4.02.The Parties intend the full terms and conditions of the compromise and settlement to be set forth in this Settlement Agreement.

4.03.In consideration of the agreements, representations, and warranties contained within this Settlement Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

V.Representations and Warranties

The following representations and warranties shall survive the execution of this Settlement Agreement and the completion of the settlement provided below:

Capacity and Authority

5.01.Subject only to the requirement of Bankruptcy Court approval, the Debtors warrant and represent that they have the power, authority, and capacity to enter into this Settlement Agreement and that this Settlement Agreement and all documents to which they are parties delivered pursuant hereto are valid, binding, and enforceable upon them and their respective principals.  

5.02.The Alpine Entities warrant and represent that they have the power, authority, and capacity to enter into this Settlement Agreement and that this Settlement Agreement and all documents to which they are parties delivered pursuant hereto are valid, binding, and enforceable upon them and their respective principals.

5.03.Except as provided in this Settlement Agreement, including the requirement of Bankruptcy Court approval, the Parties warrant and represent that no consent, approval, or authorization of, and no notice to, or filing with, any court, governmental authority, person or entity is required for the execution, delivery, and performance of this Settlement Agreement.  

No Assignment

5.03.The Parties warrant and represent that they own the claim or claims released in this Settlement Agreement and that no part of their claim or claims has been assigned or transferred to any other person or entity.

VI.Settlement Terms

In reliance upon the representations, warranties, and covenants in this Settlement Agreement, the Parties have settled and compromised the Disputes by agreeing to the following:

Payments to the Company

6.01.The Alpine Entities shall cause to be paid to the Company: (a) the total amount of the Escrowed Funds, which includes the principal amount of NINETEEN MILLION TWO-HUNDRED FIFTY-THOUSAND U.S. DOLLARS ($19,250,000.00), together with any investment earnings or income thereon; and (b) the amount of TWO MILLION EIGHT-HUNDRED SEVENTY-FIVE THOUSAND U.S. DOLLARS ($2,875,000.00) (collectively, the “Settlement Amount”), which shall be paid as set forth below.

6.02.On or before the Closing Date, the Alpine Entities and the Company shall cause to be executed and delivered the Joint Written Direction, in the form attached as Exhibit B (in accordance with the terms set forth herein), to the Escrow Agent requiring the Escrow Agent to disburse to the Company the Escrowed Funds in immediately available funds via wire transfer to the following account:

Approach Resources Inc.

JPMorgan Chase Bank, N.A.

Account Number: [***]

ABA Routing Number: [***]

 

6.03.On or before the Closing Date, the Alpine Entities shall cause to be paid to the Company TWO MILLION EIGHT-HUNDRED SEVENTY-FIVE THOUSAND U.S. DOLLARS ($2,875,000.00) in immediately available funds via wire transfer to the following account:

Approach Resources Inc.

JPMorgan Chase Bank, N.A.

Account Number: [***]

ABA Routing Number: [***]

Evidence of Inability to Perform the Purchase Agreement

6.04.On or before the Execution Date, the Alpine Entities shall cause to be delivered to the Company documents sufficient to show that the Alpine Entities do not have cash, 

unencumbered assets, or committed capital materially in excess of the Settlement Amount. Documents or information provided by the Alpine Entities pursuant to this section 6.04 shall be treated as confidential materials and, to the extent filed with the Bankruptcy Court in connection with the Bankruptcy Court Approval Order, shall be filed under seal and any reference to information in such documents shall be redacted from filings on the public docket; provided that the Debtors need not redact statements in any pleading indicating that this section 6.04 has been satisfied.  

Approval by the Bankruptcy Court

6.05.Within two (2) business days of the Execution Date, the Debtors shall submit this Settlement Agreement to the Bankruptcy Court for approval by motion pursuant to Federal Rule of Bankruptcy Procedure 9019, in the form attached as Exhibit C, along with a proposed order in the form attached as Exhibit D.

Actions related to the Motion to Compel and the Motion to Strike

6.06.On or before the Closing Date, the Alpine Entities shall cause to be filed under seal with the Bankruptcy Court an amended Motion to Compel that omits any allegations of fraud and related allegations concerning intentional deceptive conduct.

6.07.On or before the Closing Date, the Debtors shall cause to be filed with the Bankruptcy Court a notice of withdrawal with prejudice of the Motion to Strike.

Termination of the Purchase Agreement

6.08.Immediately following the Company’s receipt of the Settlement Amount, and without further action by the Parties, the Purchase Agreement shall terminate pursuant to Section 13.1(a) of the Purchase Agreement.

6.09.To the extent the terms of this Settlement Agreement conflict with, or are inconsistent with, the terms of Purchase Agreement (including, for the avoidance of doubt, Section 13.3 of the Purchase Agreement), the terms of this Settlement Agreement shall prevail.

VII.Mutual General Release

7.01.The releases contained in paragraphs 7.02 and 7.03 below are expressly conditioned on, and shall not take effect until, the Company receives the Settlement Amount as provided in paragraphs 6.01, 6.02, and 6.03 above.

7.02.The Alpine Entities hereby generally release and forever discharge the Debtor Releasees from any and all claims, grievances, sanctions, demands, and causes of action, of whatever kind or character, whether in law or in equity, which the Alpine Entities have or may have in the future, whether known or unknown, based upon any events that have occurred prior to the Execution Date, including but not limited to all claims which have been or could have been asserted in the Disputes.  This release is to be construed as the broadest form of general release and, except as expressly set forth herein, includes all claims, whether known or unknown, based upon any events that have occurred prior to the Execution Date.  Notwithstanding the foregoing description of the scope of this release, nothing herein should be construed as releasing any obligation or duty undertaken in this Settlement Agreement.

7.03.The Debtors hereby generally release and forever discharge the Alpine Releasees from any and all claims, grievances, sanctions, demands, and causes of action, of whatever kind or character, whether in law or in equity, which the Debtors have or may have in the future, whether known or unknown, based upon any events that have occurred prior to the Execution Date, including but not limited to all claims which have been or could have been asserted in the Disputes.  This release is to be construed as the broadest form of general release and, except as expressly set 

forth herein, includes all claims, whether known or unknown, based upon any events that have occurred prior to the Execution Date.  Notwithstanding the foregoing description of the scope of this release, nothing herein should be construed as releasing any obligation or duty undertaken in this Settlement Agreement.

VIII.Attorneys’ Fees

8.01.The Parties shall bear their own attorneys’ fees and costs incurred in connection with the Disputes, and in connection with this Settlement Agreement.

IX.Choice of Law

9.01.This Settlement Agreement shall be governed and construed in accordance with the laws of the State of Texas, except that any conflict of law rule of that jurisdiction that may require reference to the laws of some other jurisdiction shall be disregarded.

X.Miscellaneous

10.01.The Parties expressly warrant and represent and hereby state that no promise or agreement, which is not herein expressed, has been made to them in executing this Settlement Agreement; that they are not relying upon any statement or representation of any opposing Party or any opposing Party’s agents or representatives; that they are relying on their own judgment in the execution of this Settlement Agreement; that they are knowingly waiving any claim that this Settlement Agreement was induced by any misrepresentations or nondisclosure; and that they are knowingly waiving any right to rescind, amend, or avoid this Settlement Agreement based upon presently existing facts, known or unknown.

10.02.This Settlement Agreement shall continue perpetually and shall be binding upon the Parties and their successors and assigns, and shall inure to the benefit of the Parties and their successors and assigns.  For the avoidance of doubt, “successors and assigns” shall include any 

trustee that may be appointed in the Bankruptcy Cases or any party seeking to act on behalf of any Debtor in the Bankruptcy Cases.

10.03.This Settlement Agreement represents the entire agreement among the Parties and supersedes all prior written or oral agreements, and the terms are contractual and not mere recitals.

10.04.This Settlement Agreement may not be amended, altered, modified, or changed in any way except in writing signed by all the Parties.  

10.05.Each of the Parties expressly warrants that it has consulted legal counsel concerning the Disputes and the terms of this Settlement Agreement.  Each of the Parties further expressly warrants that its counsel has explained the provisions of this Settlement Agreement, including all attachments and the scope of the releases contained herein.  Each of the Parties expressly warrants that it fully understands the terms of this Settlement Agreement and that it signs this Settlement Agreement as its own free act.

10.06.This Settlement Agreement has been prepared by the joint efforts of counsel

for the Parties. 

10.07. This Settlement Agreement shall not in any manner constitute an admission of liability or wrongdoing on the part of any of the Parties.  Each of the Parties expressly denies any such liability or wrongdoing.  The Parties enter into this Settlement Agreement in compromise and settlement of the Disputes and for the sole purpose of avoiding further trouble and expense.  Except to the extent necessary to enforce this Settlement Agreement, neither this Settlement Agreement nor any part of it may be construed as, used, or admitted into evidence in any judicial, administrative, or arbitral proceeding, as an admission of any kind by any of the Parties.  

10.08.This Settlement Agreement may be executed in counterparts with the same effect as if the signatures hereto and thereto were upon the same instrument.

10.09.Each Party agrees to cooperate and, if necessary, execute additional documents or take additional actions to effectuate the terms and provisions of this Settlement Agreement.

10.10.All notices and other communications under this Settlement Agreement shall be in writing and will be deemed given (a) when delivered personally by hand, (b) when sent by email (with written confirmation of transmission) or (c) one (1) business day following the day sent by overnight courier (with written confirmation of receipt), in each case at the following addresses and email addresses (or to such other address or email address as a Party may have specified by notice given to the other Party pursuant to this provision):

If to the Debtors:

Approach Resources Inc.

One Ridgmar Centre

6500 West Freeway, Suite 900

Fort Worth, Texas 76116

Attention:  Josh Dazey

Email:  jdazey@approachresources.com

 

With a copy (which will not constitute notice) to:

 

Thompson & Knight, LLP

1722 Routh Street, Suite 1500

Dallas, TX  75201

Attention:  Stephen Rasch

     David Bennett

Email:  Stephen.Rasch@tklaw.com

 David.Bennett@tklaw.com

 

If to Alpine Acquisitions or Alpine Capital:

Alpine Energy Capital

3322 West End Avenue Suite 450

Nashville, TN 37203

Attention:  Chrystie Holmstrom

Email:  cholmstrom@ae-cap.com

 

With a copy (which will not constitute notice) to:

 

Skadden, Arps, Slate, Meagher & Flom LLP

1000 Louisiana, Suite 6800

Houston, TX 77002

Attention:  Kenneth Held

     Noelle Reed

Email: Kenneth.Held@skadden.com

  Noelle.Reed@skadden.com

  

and

 

Rapp & Krock, PC 

Post Oak Blvd, Suite 1200 

Houston, TX 77056 

Attention:  Henry Flores

Email:  hflores@rappandkrock.com 

 

10.11.The Parties agree that any and all proceedings related to this Settlement Agreement will be filed and maintained only in the Bankruptcy Court, and the Parties hereby consent to and submit to the jurisdiction and venue of the Bankruptcy Court for such purposes and will receive notices at such locations as indicated in paragraph 10.10 above.

10.12.WAIVER OF JURY TRIAL. THE PARTIES EXPRESSLY AND IRREVOCABLY WAIVE ANY RIGHT TO TRIAL BY JURY FOR ANY CLAIM, COUNTERCLAIM, ACTION OR OTHER PROCEEDINGS ARISING UNDER OR RELATING TO THIS SETTLEMENT AGREEMENT, ANY RIGHTS OR OBLIGATIONS HEREUNDER, THE PERFORMANCE OF SUCH RIGHTS AND OBLIGATIONS OR THE RELATIONSHIP BETWEEN THE PARTIES, IN EACH CASE WHETHER SUCH CLAIM, COUNTERCLAIM, ACTION OR OTHER PROCEEDING IS NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE.

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

AGREED:

 

APPROACH RESOURCES INC.

 

 

By: /s/ Sergei Krylov

Name: Sergei Krylov

Title: President and Chief Executive Officer

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TEXAS
	
§

§

§

COUNTY OF TARRANT§

 

BEFORE ME, the undersigned authority, on this date personally appeared Sergei Krylov, the President and Chief Executive Officer of Approach Resources Inc., known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 9th day of June, 2020.

 

J.K. Brite III

Notary Public in and for

The State of Texas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Approach Midstream Holdings LLC

 

 

By: /s/ Sergei Krylov

Name: Sergei Krylov

Title: President and Chief Executive Officer

 

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TEXAS
	
§

§

§

COUNTY OF TARRANT§

 

BEFORE ME, the undersigned authority, on this date personally appeared Sergei Krylov, the President and Chief Executive Officer of Approach Midstream Holdings LLC, known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 9th day of June, 2020.

 

J.K. Brite III

Notary Public in and for

The State of Texas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

APPROACH OIL & GAS INC.

 

 

By: /s/ Sergei Krylov

Name: Sergei Krylov

Title: President and Chief Executive Officer

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TEXAS
	
§

§

§

COUNTY OF TARRANT§

 

BEFORE ME, the undersigned authority, on this date personally appeared Sergei Krylov, the President and Chief Executive Officer of Approach Oil & Gas Inc., known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 9th day of June, 2020.

 

J.K. Brite III

Notary Public in and for

The State of Texas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

APPROACH RESOURCES I, LP

 

By: /s/ Sergei Krylov

Name: Sergei Krylov

Title: President and Chief Executive Officer

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TEXAS
	
§

§

§

COUNTY OF TARRANT§

 

BEFORE ME, the undersigned authority, on this date personally appeared Sergei Krylov, the President and Chief Executive Officer of Approach Resources I, LP, known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 9th day of June, 2020.

 

J.K. Brite III

Notary Public in and for

The State of Texas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Approach Delaware, LLC

 

By: /s/ Sergei Krylov 

Name: Sergei Krylov

Title: President and Chief Executive Officer

 

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TEXAS
	
§

§

§

COUNTY OF TARRANT§

 

BEFORE ME, the undersigned authority, on this date personally appeared Sergei Krylov, the President and Chief Executive Officer of Approach Delaware, LLC, known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 9th day of June, 2020.

 

J.K. Brite III

Notary Public in and for

The State of Texas

APPROACH OPERATING, LLC

 

By: /s/ Sergei Krylov

Name: Sergei Krylov

Title: President and Chief Executive Officer

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TEXAS
	
§

§

§

COUNTY OF TARRANT§

 

BEFORE ME, the undersigned authority, on this date personally appeared Sergei Krylov, the President and Chief Executive Officer of Approach Operating, LLC, known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 9th day of June, 2020.

 

J.K. Brite III

Notary Public in and for

The State of Texas

 

 

APPROACH SERVICES, LLC

 

By: /s/ Sergei Krylov

Name: Sergei Krylov

Title: President and Chief Executive Officer

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TEXAS
	
§

§

§

COUNTY OF TARRANT§

 

BEFORE ME, the undersigned authority, on this date personally appeared Sergei Krylov, the President and Chief Executive Officer of Approach Services, LLC, known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 9th day of June, 2020.

 

J.K. Brite III

Notary Public in and for

The State of Texas

 

 

 

 

 

 

 

 

 

 

 

ALPINE ENERGY ACQUISITIONS, LLC

By: /s/ Craig Perry

Name: Craig Perry

Title: President and Chief Executive Officer

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TN
	
§

§

§

COUNTY OF Davidson§

 

BEFORE ME, the undersigned authority, on this date personally appeared Craig Perry, the President and Chief Executive Officer of Alpine Energy Acquisitions, LLC, known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 3rd day of June, 2020.

 

/s/ Tiffany B. Vinson

Notary Public in and for

      The State of TN

 

 

 

 

 

 

 

 

 

 

ALPINE ENERGY CAPITAL, LLC

 

By: /s/ Craig Perry

Name: Craig Perry

Title: President and Chief Executive Officer

 

ACKNOWLEDGMENT:

 

 

	
STATE OF TN
	
§

§

§

COUNTY OF Davidson§

 

BEFORE ME, the undersigned authority, on this date personally appeared Craig Perry, the President and Chief Executive Officer of Alpine Energy Capital, LLC, known to me to be the person whose name is subscribed to the foregoing instrument, and acknowledged to me that he executed the same for the purposes and consideration therein expressed.

 

GIVEN under my hand and seal this 3rd day of June, 2020.

 

/s/ Tiffany B. Vinson

Notary Public in and for

      The State of TN

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit A

 

[Purchase Agreement]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit B

 

[Joint Written Direction]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit C

 

[Rule 9019 Motion]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit D

 

[Proposed Order granting Rule 9019 Motion]Exhibit
4.1

 

NEITHER
THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED (THE “SECURITIES”) HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A CUSTOMARY FORM, THAT REGISTRATION
IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 UNDER SAID ACT.

 

COMMON
STOCK PURCHASE WARRANT

ONCBIOMUNE
PHARMACEUTICALS, INC.

 

Warrant
Shares: Issue Date: June 5, 2020

Initial
Exercise Date: September 5, 2020

 

THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________,
an                    or its
assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after September 5, 2020 (the “Initial Exercise Date”)
and on or prior to the close of business on September 5, 2025, (the “Termination Date”, provided, however,
that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day (as defined
below)) but not thereafter, to subscribe for and purchase from ONCBIOMUNE PHARMACEUTICALS, INC., a Nevada corporation
(the “Company”), up to
                     
shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of
one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section
2(b).

 

Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the “Securities Purchase Agreement”), dated May 12, 2020, by and among the Company
and the other parties thereto signatory thereto.

 

Section
2. Exercise.

 

a)
Exercise of Warrant. This Warrant is not exercisable until sixty (60) days after the Company effectuates a reverse stock
split and the Company achieves and maintains a Market Capitalization of $50,000,000 for thirty (30) consecutive days, at which
it will become exercisable until the Termination Date; provided, however, this requirement may be waived by the Executive Chairman
or the Chief Executive Officer of the Company at any time. For purposes of this Section, “Market Capitalization” means
the product equal to (a) the closing stock price of the Common Stock, multiplied by (b) the aggregate number of outstanding shares
of Common Stock as reported on Company’s most recently filed Form 10-Q or Form 10-K plus the number of shares of common
stock all currently convertible and outstanding common share equivalent securities are convertible into. Subject to the forgoing,
exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after
the Initial Exercise Date and on or before the Termination Date by delivery to the Company or the Transfer Agent (or such other
office or agency that the Company may designate by notice in writing to the registered Holder at the address of the Holder appearing
on the books of the Company), as applicable, of a duly executed facsimile copy or PDF copy submitted by electronic (or e-mail
attachment) of the Notice of Exercise in the form annexed hereto. Within the earlier of (i) three (3) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date
of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice
of Exercise by wire transfer unless the cashless exercise procedure specified in Section 2(c) below is specified in the
applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the
Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to
the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of
Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within
one (1) Business Day of receipt of such notice. The Holder, by acceptance of this Warrant, acknowledges and agrees that, by
reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

    	 	-1-	 

    	 	 	 

    

 

b)
Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $0.0025, subject to adjustment
hereunder (the “Exercise Price”).

 

c)
Cashless Exercise. If on or after February 15, 2021, there is no effective registration statement registering, or no current
prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or
in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

	 	(A) =	 as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a)
hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(64) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock
on the principal market for the common stock as reported by Bloomberg L.P. as of the time of the Holder’s execution of the
applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day
and is delivered within two (2) hours thereafter pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
Exercise Notice if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
	 	(B) =	the Exercise Price of this Warrant, as adjusted hereunder;
and
	 	(X) =	the number of Warrant Shares that would be issuable
upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather
than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company
agrees not to take any position contrary to this Section 2(c).

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed on the Nasdaq Capital Market or another national securities exchange, the bid price of the Common Stock for
the time in question (or the nearest preceding Trading Day) on such exchange on which the Common Stock is then listed as reported
by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common
Stock is then quoted on the OTCQB or OTCQX, the volume weighted average price of the Common Stock for such date (or the nearest
preceding Trading Day) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on a
national securities exchange or OTCQB or OTCQX, and if prices for the Common Stock are then reported in the “Pink Sheets”
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the
most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of
Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the
Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

    	 	-2-	 

    	 	 	 

    

 

“Trading
Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock,
any day on which the Common Stock is traded on the principal securities exchange or securities market on which the Common Stock
is then traded, provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade
on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final
hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading
on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated
as a Trading Day in writing by the Holder or (y) with respect to all determinations other than price determinations relating to
the Common Stock, any day on which The Nasdaq Capital Market (or any successor thereto) is open for trading of securities.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed on the Nasdaq Capital Market or another national securities exchange, the daily volume weighted average price of the Common
Stock for such date (or the nearest preceding Trading Day) on the Trading Market on which the Common Stock is then listed as reported
by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common
Stock is then quoted on the OTCQB or OTCQX, the volume weighted average price of the Common Stock for such date (or the nearest
preceding Trading Day) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on a
national securities exchange or OTCQB or OTCQX, and if prices for the Common Stock are then reported in the “Pink Sheets”
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the
most recent Bid Price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of
Common Stock as determined by an independent appraiser selected in good faith by the Investor and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.

 

d)
Mechanics of Exercise.

 

i.
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder either, at the option of the Holder, (A) crediting the account of the Holder’s or its
designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”)
if the Company is then a participant in such system and either (1) there is an effective registration statement permitting the
issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (2) this Warrant being exercised via cashless
exercise and Rule 144 (as defined in the Securities Purchase Agreement) is available, or (B) otherwise by physical delivery of
a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is three (3) Trading Days after the delivery to the Company of the Notice of Exercise (such date, the “Warrant
Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of
a cashless exercise) is received within the earlier of (i) three Trading Days and (ii) the number of Trading Days comprising the
Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the
Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date in the manner set forth in this Section
2(d)(i), the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10
per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for
each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise;
provided that such penalty shall be tolled upon payment by the Company of the concurrent penalty set forth in Section 5(e) of
the Securities Purchase Agreement. The Company agrees to maintain a transfer agent that is a participant in the FAST program so
long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means
the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect
to any Notice(s) of Exercise delivered by 12:00 p.m. (New York City time) on the Initial Exercise Date, the Company agrees to
deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date.

 

    	 	-3-	 

    	 	 	 

    

 

ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder
a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which
new Warrant shall in all other respects be identical with this Warrant.

 

iii.
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.

 

v.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid
by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice
of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions)
required for same-day electronic delivery of the Warrant Shares.

 

vi.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

e)
Holder’s Exercise Limitations. A Holder shall not have the right to exercise any portion of this Warrant, pursuant
to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable
Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together
with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of
shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of
shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall
exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion
of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common
Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes
of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to
the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act. The Holder acknowledges and agrees that
it is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained
in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership
Limitation. Notwithstanding anything to the contrary, the Company shall have no obligation to verify or confirm the accuracy of
the Holder’s determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this
Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission,
as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or
the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder,
the Company shall within three Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation”
shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue
to apply. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity
with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to
properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this
Warrant.

 

    	 	-4-	 

    	 	 	 

    

 

Section
3. Certain Adjustments.

 

a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged, subject to the limitation on fractional shares
in Section 2(d)(v). Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of
capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(other than dividends or distributions subject to Section 3(a) herein) (a “Distribution”), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the
same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the
Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such
Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to
participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such
Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

    	 	-5-	 

    	 	 	 

    

 

c)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making
or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the
Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common
Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number
of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard
to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate
Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(c) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder
in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which
applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares
of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior
to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that
from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company
and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect
as if such Successor Entity had been named as the Company herein.

 

    	 	-6-	 

    	 	 	 

    

 

f)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g)
Notice to Holder.

 

i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3,
the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a
party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered
by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register
of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that
holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure
to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the
period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.

 

Section
4. Transfer of Warrant.

 

a)
Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) is not
transferable, in whole or in part, except to the Holder’s affiliates upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender
this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning
this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.

 

    	 	-7-	 

    	 	 	 

    

 

b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be
involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the
Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall
be dated the Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section
5. Miscellaneous.

 

a)
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other
rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3(d).

 

b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case
of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.

 

c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next
succeeding Business Day.

 

d)
Authorized Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of
any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full
authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading
Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise
of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and
payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free
from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).

 

e)
No Frustration. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action,
including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action
as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant
Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant.

 

    	 	-8-	 

    	 	 	 

    

 

f)
Authorizations. Before taking any action which would result in an adjustment in the number of Warrant Shares for which
this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof,
or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

g)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Securities Purchase Agreement.

 

f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities
laws.

 

g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding
the fact that all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with
any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including
those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing
any of its rights, powers or remedies hereunder.

 

h)
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company
shall be delivered in accordance with the notice provisions of the Securities Purchase Agreement.

 

i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.

 

j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not
be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.

 

l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.

 

m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

 

n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.

 

********************

 

    	 	-9-	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date
first above indicated.

 

	 	ONCBIOMUNE
    PHARMACEUTICALS, INC.  
	 	 	 
	 	By:	 
	 	Name:	Andrew
    Kucharchuk
	 	Title:	Chief
    Executive Officer

 

    	 	-10-	 

    	 	 	 

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

To:
oncbiomune pharmaceuticals, INC.

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.

 

(2)
Payment shall take the form of (check applicable box):

 

[  ]
in lawful money of the United States; or

 

[  ]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).

 

(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

____________________________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

____________________________________

____________________________________

____________________________________

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: ___________________________________________________________________________

 

Signature
of Authorized Signatory of Investing Entity:_____________________________________________________

 

Name
of Authorized Signatory:_______________________________________________________________________

 

Title
of Authorized Signatory:________________________________________________________________________

 

Date:___________________________________________________________________________________________

 

    	 	-11-	 

    	 	 	 

    

 

EXHIBIT
B

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 
	 	(Please
    Print)
	 	 
	Address:	 
	 	(Please
    Print)
	 	 
	Phone
    Number:	 
	 	 
	Email
    Address:	 
	 	 
	Dated:
    _______________ __, ______	 
	 	 
	Holder’s
    Signature:	 
	 	 
	Holder’s
    Address:	 

 

    	 	-12-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]